QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
(This summary is based upon information released from Northwestern University in Chicago, Illinois. Prostatectomy patients of Dr. William J. Catalona were involved in the study and will be involved in future studies.) Ateam of Northwestern University researchers, using an extremely…
There’s something to be said for a casual conversation between friends. It’s how Rick Lyke committed to getting a PSA test, how it most likely saved him from advanced prostate cancer, and how he became an effective advocate for early…
Unlike many other malignancies, symptoms are uncommon early in the course of prostate cancer. Instead, symptoms such as bone pain or obstructive or irritating urinary symptoms typically do not occur until the disease is advanced and/or incurable. Accordingly, efforts are…
Two Studies: ERSPC and PLCO The Spring 2009 issue of Quest was devoted to the subject of prostate cancer screening in response to the high interest in the topic created by the publication of two studies in the New England…
I believe treatment of prostate cancer by removal of the prostate with robot-assisted laparoscopic surgery could set back by years some of the gains that have been achieved in the successful treatment of prostate cancer. The surgical technique, also referred…
It’s not easy to figure out why a thorny cactus produces such beautiful flowers. And it’s not easy to figure out why drugs that seem so effective in one area can cause harmful repercussions in another. © photo by Laurie…
Some studies have suggested that statins, in addition to their benefits for prevention of heart disease, might reduce the risk of the aggressive forms of prostate cancer. Statins are a class of drugs used to lower cholesterol levels by preventing…
The American Urological Association (AUA) is aware of recent news reports disparaging prostate cancer testing. We are concerned that these reports are causing significant confusion for patients and we wish to clarify our recommendations on prostate cancer testing with…
(deCODE Genetics and Dr. William J. Catalona have collaborated on genetic research to identify the risk factors for prostate cancer.) In September of this year, deCODE Genetics announced that a team of its scientists discovered four novel single-letter variations in…
My Father passed away in 1980 from metastatic prostate cancer, only six months after he was diagnosed. Unfortunately, it was still a few years before Dr. William Catalona began directing the research efforts of the URF and before the wide…
